What to Expect in 2015: An Overview of Potential Pharmaceutical Regulatory Policy and Enforcement Developments

Although the pharmaceutical industry has faced a rapid pace of regulatory and enforcement change in recent years, 2015 promises to be another year of important developments, some of which may have a profound impact on industry economics, responsibilities and practices, as well as the regulatory framework applicable to drug and biologic development. This Advisory is intended to assist our clients and friends by anticipating some of the more important and likely areas of change in the coming year relating to enforcement, payment policy, and Food and Drug Administration regulation.

Please click here read an Advisory further reviewing this topic.